Stocks:
5,169
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.09T
24h Vol:
$8.59B
Dominance:
MSFT:4.90%
Stocklytics Platform
Asset logo for symbol CLBT
Cellebrite DI Ltd.
CLBT
68
$12.11arrow_drop_down1.14%-$0.14

Performance History

Chart placeholder
Key Stats
Open$12.16
Prev. Close$12.25
EPS-0.58
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$2.24B
PE Ratio-
LOWHIGH
Day Range12.08
12.29
52 Week Range6.08
12.67
Ratios
P/B Ratio64.87
Revenue$325.11M
Operating M. %10.20%
Earnings$0.00
Earnings Growth %-167.13%
EBITDA Margin %16.23%
ROE %-1,768.51%
EPS-0.58

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

info
There's no data available for Analyst Forecast

Analyst Ratings

info
There's no data available for Analyst Ratings

Correlated Companies

PRICE$442.57
24H (%)arrow_drop_up0.22%
24H ($)$0.99
MARKET CAP$3.18T
PRICE$212.49
24H (%)arrow_drop_down0.81%
24H ($)-$1.75
MARKET CAP$2.91T
PRICE$131.88
24H (%)arrow_drop_up1.75%
24H ($)$2.27
MARKET CAP$2.82T
PRICE$1,735.04
24H (%)arrow_drop_up3.33%
24H ($)$56.05
MARKET CAP$644.46B

About Cellebrite DI Ltd. (CLBT)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the United States, and the Asia-Pacific. Its DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Cellebrite Pathfinder helps investigators reach conclusions faster through automated data ingestion, normalization, consolidation, and visualization of a suspects' journey; CryptoCurrency Investigative Solutions, which analyze blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets and transactions; and OSINT Investigate solution used to search, resolve, and enrich identifiers in open sources. In addition, the company provides Cellebrite Guardian, a cloud-based digital investigative data and evidence management SaaS solution that allows users to manage, store, share, and review investigative data and evidence from intake to creation of a final report; and Commander solution that enables collaboration across investigation functions to reduce manual processes. It serves federal and state and local agencies, as well as enterprise companies and service providers. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. is a subsidiary of Sun Corporation.

Sector
Technology
Industry
Software—Infrastructure
CEO
Mr. Yossi Carmil
Headquarters
Petah Tikva
Employees
1005
Exchange
NASDAQ
add Cellebrite DI Ltd. to watchlist

Keep an eye on Cellebrite DI Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Cellebrite DI Ltd.'s (CLBT) price per share?

The current price per share for Cellebrite DI Ltd. (CLBT) is $12.11. The stock has seen a price change of -$0.14 recently, indicating a -1.14% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Cellebrite DI Ltd. (CLBT)?

For Cellebrite DI Ltd. (CLBT), the 52-week high is $12.67, which is 4.62% from the current price. The 52-week low is $6.08, the current price is 99.18% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Cellebrite DI Ltd. (CLBT) a growth stock?

Cellebrite DI Ltd. (CLBT) has shown an average price growth of 0.41% over the past three years. It has received a score of 79 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cellebrite DI Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Cellebrite DI Ltd. (CLBT) stock price performance year to date (YTD)?

As of the latest data, Cellebrite DI Ltd. (CLBT) has a year-to-date price change of 43.65%. Over the past month, the stock has experienced a price change of 5.58%. Over the last three months, the change has been 4.85%. Over the past six months, the figure is 46.97%.

help
Is Cellebrite DI Ltd. (CLBT) a profitable company?

Cellebrite DI Ltd. (CLBT) has a net income of -$81.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 83.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 10.2% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $325.11M, with a revenue growth rate of 20.12%, providing insight into the company's sales performance and growth. The gross profit is $271.88M. Operating income is noted at $33.28M. Furthermore, the EBITDA is $43.95M.

help
What is the market capitalization of Cellebrite DI Ltd. (CLBT)?

Cellebrite DI Ltd. (CLBT) has a market capitalization of $2.24B. The average daily trading volume is 1.15M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level